Table 3.
Excluded studies with named reason (n = 22).
| Author (Year) | Reason for Exclusion |
|---|---|
| [47] Babu et al. (2019) | cohort → only 40.5% PAH patients |
| [48] Betancourt Pena et al. et al. (2018) | cohort → PH secondary to lung disease |
| [49] Brown et al. et al. (2015) | intervention → acute exercise |
| [50] Chia et al. (2017a) | type of article → study protocol |
| [51] Favret et al. et al. (2006) | cohort → no MCT-induced PAH in rats |
| [52] Fowler et al. et al. (2013) | intervention → acute exercise |
| [53] Ganderton et al. (2011) | type of article → study protocol |
| [54] Goret et al. et al. (2005) | cohort → no MCT-induced PH in rats |
| [55] Harbaum et al. (2016) | intervention → acute exercise |
| [56] Hargett et al. (2015) | cohort → no MCT-induced PAH in rats |
| [57] Ihle F et al. (2014) | cohort → PH, but no data if ≥ 70% PAH |
| [58] Laoutaris et al. et al. (2016) | cohort → no PAH |
| [59] Morris et al. (2018) | type of article → study protocol |
| [60] Postolache et al. et al. (2018) | cohort → case study; patient with PH, but no PAH |
| [61] Saglam et al. (2015) | intervention → exclusive inspiratory muscle training |
| [62] Sanchis-Gomar et al. (2015) | type of article → study rationale and design |
| [63] Santos-Lozano et al. (2017) | no sufficient/inconsistent information |
| [64] Spruijt et al. (2015) | intervention → acute exercise |
| [65] Uchi et al. (2005) | cohort → patients aged 5–37 years |
| [66] Weissmann et al. (2014) | cohort → no MCT-induced PAH in rats |
| [67] Woolstenhulme et al. (2019) | outcome measures → examined only LV function |
| [68] Zöller et al. (2017) | cohort → patients minimum age of 5 years |
LV, left ventricular; MCT, monocrotaline; PAH, pulmonary arterial hypertension; PH, pulmonary hypertension.